FDA’s RWE Program will be multifaceted. It will involve demonstration projects, stakeholder engagement, internal processes to bring senior leadership input into the evaluation of RWE and promote shared learning and consistency in applying the framework, and guidance documents to assist developers interested in using real-world data (RWD) to develop RWE to support Agency regulatory decisions. This document outlines the framework FDA plans to use to implement its RWE Program
Read here: